Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of remimazolam tosilate plus fentanyl for minimally invasive breast surgery under ERAS
ChiCTR2400085279Phase 4Not yet recruiting
- Sponsor
- Haining People's Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in breast lesion, sponsored by Haining People's Hospital. Primary endpoint: Body movement reaction. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
breast lesion
Beyond the preview
Go deeper on ChiCTR2400085279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085279.